InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: hovacre post# 96249

Sunday, 03/31/2019 12:05:40 PM

Sunday, March 31, 2019 12:05:40 PM

Post# of 108192
Thank you for being one of the voices of reason and sanity here. Obviously, neither Amgen nor Merck had enough clinical evidence to assess the efficacy of the treatments despite the claims of others. I'm hoping more light is shed on the responses of the six patients. There appear to be a number of patients (23) in Part B <50% PSA decline from baseline (according to the slide on the CP) who had not had an event, also. Would to hear an update on them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News